PALI
PALISADE BIO, INC.
NASDAQ · Healthcare · Biotechnology · US
$1.59
−6.47%Jun 29, 2026, 12:30 UTC
Palisade Bio received FDA clearance of its Investigational New Drug application for PALI-2108.
Source:
NASDAQ · Healthcare · Biotechnology · US
Jun 29, 2026, 12:30 UTC